Top Partnering Opportunities In Oncology: Broad Efficacy Leads To Broad Appeal
Executive Summary
Partner-ready oncology assets cut across diverse fields, including drug conjugates, vaccines and cancer metabolism, with many likely to become part of early-stage deals with shared risk.